Global Burden of Elevated LDL-C
GBD 2023 LDL Cholesterol Collaborators, Christian Razo, Nicole K. DeCleene, Catherine O. Johnson et autres
3 citationsJAMA
Sparta Cancer Center
Sussex · US · healthcare
25Publications signalées
533Citations signalées
12Thèmes principaux
Principaux domaines
Advanced Radiotherapy TechniquesColorectal Cancer Treatments and StudiesCancer Genomics and DiagnosticsDiabetes, Cardiovascular Risks, and LipoproteinsCancer Cells and MetastasisOpioid Use Disorder TreatmentProtease and Inhibitor MechanismsMultiple Myeloma Research and TreatmentsForensic Toxicology and Drug AnalysisGenetic factors in colorectal cancerCardiovascular Health and Risk FactorsSubstance Abuse Treatment and Outcomes
Évolution annuelle
Publications récentes
Modifiable Risk Factors and Attributable Ischemic Heart Disease Mortality in US States, 1990-2023
Catherine P. Benziger, Benjamin A. Stark, Catherine O. Johnson, Gregory A. Roth et autres
1 citationJAMA Cardiology
Author Correction: Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
Jiseung Kang, Hyeon Jin Kim, Min Seo Kim, GBD 2023 Substance Use Collaborators et autres
0 citationsNature Medicine
Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990–2023: a Global Burden of Disease study
GBD 2023 IHD & Dietary Risk Factors Collaborators, Sooji Lee, Hayeon Lee, Yejun Son et autres
3 citationsNature Medicine
Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
Jiseung Kang, Hyeon Jin Kim, Min Suk Kim, GBD 2023 Substance Use Collaborators et autres
20 citationsNature Medicine
The impact of Duffy genotype on progression-free survival (PFS) with lenalidomide, Bortezomib, and dexamethasone (RVd) alone or RVd plus autologous stem cell transplantation (ASCT) and continuous R maintenance in patients (pts) with newly diagnosed multiple myeloma (NDMM): Updated subgroup analysis of the phase 3 DETERMINATION trial
Lauren E. Merz, Rebecca L. Zon, Susanna Jacobus, Mehmet Samur et autres
1 citationBlood
A randomized phase II study of daratumumab, lenalidomide, ixazomib, and dexamethasone in transplant-ineligible or deferred patients with newly diagnosed multiple myeloma: Alliance Foundation Trial 41 (AFT-41)
0 citationsBlood
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage
Ilari Rautalin, Victor Volovici, Benjamin Stark, Catherine O. Johnson et autres
43 citationsJAMA Neurology
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
Marissa B Reitsma, Yohannes Abate, Abdallah H A Abd Al Magied, Atef Abdelkader et autres
143 citationsThe Lancet Public Health
A Potential Blind Spot in Breast Radiotherapy: The Importance of Volume in Breast Boosts
1 citationClinical Oncology
A family of novel TEAD palmitoylation site inhibitors with exceptional pre-clinical anti-neoplastic activity as a monotherapy and in combination with MAPK inhibitors
Florian L. Müller, D. Warshaviak, J. Gyuris, R. Nir et autres
0 citationsEuropean Journal of Cancer
Validation study of end-of-life risk prediction model in active chemotherapy patients.
Melinda S. Hill, May D. Abdo-Matkiwsky, Noa Biran, Jumana Chatiwala et autres
0 citationsJournal of Clinical Oncology
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.